CD4+ T lymphocytes mediate hypercholesterolemia-induced endothelial dysfunction via a NAD(P)H oxidase-dependent mechanism

American Journal of Physiology. Heart and Circulatory Physiology
Ryan M WolfortD N Granger

Abstract

Although hypercholesterolemia is known to impair endothelium-dependent vasodilation (EDV) long before the appearance of atherosclerotic plaques, it remains unclear whether the immune mechanisms that have been implicated in atherogenesis also contribute to the early oxidative stress and endothelial cell dysfunction elicited by hypercholesterolemia. EDV (wire myography), superoxide generation (cytochrome c reduction), and NAD(P)H oxidase mRNA expression were monitored in aortic rings from wild-type (WT) and mutant mice placed on either a normal diet or a cholesterol-enriched diet (HC) for 2 wk. WT mice on HC exhibited impaired EDV, enhanced superoxide generation, and increased expression of NAD(P)H oxidase subunit Nox-2 mRNA. The impaired EDV and increased superoxide generation induced by HC were significantly blunted in severe combined immunodeficient (SCID) mice and CD4+ T lymphocyte-deficient mice. These responses were also attenuated in HC mice genetically deficient in IFN-gamma; however, adoptive transfer of WT-HC CD4+ T lymphocytes to IFN-gamma-deficient recipients restored HC-induced responses. The HC-induced impaired EDV and oxidative stress were also attenuated in HC mice genetically deficient in Nox-2 (gp91(phox-/-)) an...Continue Reading

References

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G K HanssonJ Fingerle
Jul 18, 1986·Cell·R RossD F Bowen-Pope
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B PaigenR C LeBoeuf
May 1, 1981·The Journal of Physiology·M J Mulvany, D M Warshaw
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·S StemmeG K Hansson
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Jun 1, 1997·The Journal of Clinical Investigation·S GuptaC Schindler
May 29, 1998·Journal of Molecular and Cellular Cardiology·C H SelzmanA H Harken
Nov 14, 2000·Circulation Research·H Cai, D G Harrison
Jun 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·L V d'UscioZ S Katusic
Nov 21, 2001·The Journal of Clinical Investigation·K K Griendling, D G Harrison
Oct 11, 2002·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Karen Y StokesD Neil Granger
May 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Marisa BenagianoGianfranco Del Prete
Jan 28, 2004·Circulation·Jaikirshan J KhatriZorina S Galis
Jan 22, 2005·Circulation Research·Xinghua ZhouGöran K Hansson
Dec 3, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Jamila Khallou-LaschetAntonino Nicoletti
Dec 24, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Godfrey S Getz, Catherine A Reardon
Feb 8, 2006·Nature Medicine·Hafid Ait-OufellaZiad Mallat
Jul 4, 2006·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Karen Y StokesD Neil Granger
Jun 15, 2007·Free Radical Biology & Medicine·Karen Y StokesD Neil Granger
Jun 23, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Karen Y StokesD Neil Granger
Sep 19, 2007·The Journal of Experimental Medicine·Tomasz J GuzikDavid G Harrison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.